Nifedipine-maintained tocolysis no benefit in perinatal outcomes

January 4, 2013
Nifedipine-maintained tocolysis no benefit in perinatal outcomes
For women threatened with preterm labor, maintenance tocolysis with nifedipine is not associated with a significant reduction in adverse perinatal outcomes, according to a study published in the Jan. 1 issue of the Journal of the American Medical Association.

(HealthDay)—For women threatened with preterm labor, maintenance tocolysis with nifedipine is not associated with a significant reduction in adverse perinatal outcomes, according to a study published in the Jan. 1 issue of the Journal of the American Medical Association.

Carolien Roos, M.D., from the Radboud University Medical Center in Nijmegen, Netherlands, and colleagues conducted a randomized, double-blind, placebo-controlled study in 11 perinatal units in all tertiary centers in the Netherlands to examine whether maintenance tocolysis with nifedipine would reduce adverse perinatal outcome linked to premature birth. with threatened preterm labor between 26 and 32 weeks of gestation, who had not delivered after 48 hours of tocolysis and a completed course of corticosteroids, were randomized to oral nifedipine (201 women) or placebo (205 women) for 12 days. Surviving infants were followed for six months.

The researchers observed no significant between-group difference in adverse perinatal outcome (11.9 percent for nifedipine versus 13.7 percent for placebo; relative risk, 0.87; 95 percent confidence interval, 0.53 to 1.45).

"It seems likely that the absence of any effect is not due to ineffectiveness of nifedipine as a uterine relaxant," the authors write. "Apparently, symptomatic treatment of uterine contractions with any uterine relaxant is ineffective when used as . The etiology of threatened preterm labor is multifaceted and includes subclinical intrauterine infection. Future research should be directed toward therapies tailored to the specific underlying causes of ."

One author disclosed a financial tie to CSL Behring, and one author reported provision of expert testimony to courts, payment for lectures, and private/unrelated stock/stock options.

Explore further: Vaginal progesterone reduces preterm birth, neonatal morbidity and mortality in women at risk

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Vaginal progesterone reduces preterm birth, neonatal morbidity and mortality in women at risk

December 14, 2011
Women with a short cervix should be treated with vaginal progesterone to prevent preterm birth, according to a landmark study by leading obstetricians around the world. Vaginal progesterone decreased the rate of preterm birth ...

No increase in preterm delivery with Ramadan fasting

August 7, 2012
(HealthDay) -- Pregnant women who fast during the month of Ramadan do not have an increased risk of preterm delivery, regardless of when during gestation the fasting occurs, according to research published online July 25 ...

Study shows progesterone fails to prevent preterm birth in high risk group

October 18, 2012
(Medical Xpress)—A formulation of the hormone progesterone, shown to be effective in women at risk for another preterm birth because they had a prior preterm birth, was not found to be effective in preventing preterm birth ...

Recommended for you

Negative birth outcomes linked to air pollution exposure early in pregnancy, study finds

July 27, 2017
Exposure to air pollution early in a pregnancy could increase risk for preterm birth and low birth weight, according to a study led by researchers at NYU School of Medicine, and published on July 27 in Environmental Health ...

Study shows a significant ongoing decline in sperm counts of Western men

July 25, 2017
In the first systematic review and meta-analysis of trends in sperm count, researchers from the Hebrew University-Hadassah Braun School of Public Health and Community Medicine and the Icahn School of Medicine at Mount Sinai ...

Women exposed to smoke while in womb more likely to miscarry

July 13, 2017
Women exposed to cigarette smoke while in their mothers' wombs are more likely to experience miscarriage as adults, according to new research from the University of Aberdeen.

Lack of a hormone in pregnant mice linked to preeclampsia

June 30, 2017
(Medical Xpress)—A team of researchers from Singapore, the Netherlands and Turkey has isolated a hormone in pregnant mice that appears to be associated with preeclampsia—a pregnancy-related condition characterized by ...

Aspirin reduces risk of pre-eclampsia in pregnant women

June 28, 2017
Taking a low-dose aspirin before bed can reduce the risk of pre-eclampsia, which can cause premature birth and, in extreme cases, maternal and foetal death.

The biology of uterine fluid: How it informs the fetus of mom's world

June 22, 2017
A developing fetus bathes in a mixture of cellular secretions and proteins unique to its mother's uterus. Before fertilization, the pH of uterine fluid helps create a conducive environment for sperm migration, and afterward, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.